Immuron (IMRN) Net Income (2016 - 2024)

Immuron (IMRN) recorded quarterly Net Income of $1660259165.7 billion in Q4 2024, up 80082653894884.78% quarter-over-quarter from -$2.1 million in Q4 2023, and up 80082653894884.8% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Net Income (2016 - 2024) Analysis & Trends

Immuron's Net Income history runs 9 years deep, the most recent figure standing at $1660259165.7 billion for Q4 2024.

  • In Q4 2024, Net Income rose 80082653894884.8% year-over-year to $1660259165.7 billion; the TTM figure through Sep 2025 stood at $1660259165.7 billion (up 80082653894884.8% YoY), while the FY2025 annual figure was -$3.4 million, up 25.69% from the prior year.
  • Net Income was $1660259165.7 billion for Q4 2024 at Immuron, up from -$2.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1660259165.7 billion in Q4 2024 to a low of -$2.1 million in Q4 2023.
  • Historically, Net Income has averaged $276709860.9 billion across 5 years, with a median of -$35323.9 in 2020.
  • The sharpest annual moves came in 2023 and 2024: Net Income tumbled 15849.51% in 2023, then jumped 80082653894884.8% in 2024.
  • A 5-year view of Net Income shows it stood at -$57387.7 in 2020, then soared by 76.89% to -$13260.2 in 2021, then climbed by 1.97% to -$12998.4 in 2022, then sank by 15849.51% to -$2.1 million in 2023, then surged by 80082653894884.78% to $1660259165.7 billion in 2024.
  • The last three Net Income figures came in at $1660259165.7 billion (Q4 2024), -$2.1 million (Q4 2023), and -$1.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,660,259,165.67 Bn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -12,998.41
Dec 31, 2021 -13,260.17
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.84 Mn
Dec 31, 2016 2.56 Mn
Jun 30, 2016 -3.28 Mn